# IBA

> Particle accelerator technology leader

Business model and tags: B2B, Manufacturing, Hardware, Multi-product, Sales-led purchase, Medical devices, Sells to enterprises, International operations, Has in-house R&D

## About IBA

A global leader in particle accelerator technology, providing advanced proton therapy equipment and services, as well as solutions in industrial sterilization and radiopharmaceuticals

## Key facts

- **Industry**: Medical Equipment Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Louvain-la-Neuve, Wallonia, Belgium
- **Founded**: 1986
- **Revenue**: €620M (FY2025, publicly reported)
- **SIREN**: [391640679](https://annuaire-entreprises.data.gouv.fr/entreprise/391640679)
- **Website**: [iba-group.com](http://iba-group.com)
- **LinkedIn**: [linkedin.com/company/iba](https://www.linkedin.com/company/iba)

## IBA account plan

IBA is a Belgian particle-accelerator group in proton therapy, dosimetry, radiopharma and industrial sterilization, with EUR 620.2 million sales in 2025.

[Read the IBA account plan](https://www.tamtam.ai/c/iba/account-plan)

## IBA at a glance

IBA is a B2B company in the Medical Equipment Manufacturing industry, headquartered in Louvain-la-Neuve, Wallonia, Belgium.

IBA was founded in 1986.

IBA has 1,001–5,000 employees.

IBA's revenue is €620M (FY2025, publicly reported).

IBA's SIREN number is 391640679.

## Frequently asked questions about IBA

### What is IBA's revenue?

IBA's revenue is €620M (FY2025, publicly reported).

### How many employees does IBA have?

IBA has 1,001–5,000 employees.

### Where is IBA headquartered?

IBA is headquartered in Louvain-la-Neuve, Wallonia, Belgium.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/iba
